Micropoint Technologies is an Information Technology startup that was founded in 2008. The company focuses on commercializing microneedle technology, particularly in the transdermal drug delivery and diagnostic industry. They not only develop and supply their own products but also offer customization services tailored to their clients' specific requirements.
The company secured its last Series A investment on 27 August 2012. The investors in this round were Mercatus Capital and GITPx. With a strong focus on innovative technology and a commitment to meeting the specific needs of their clients, Micropoint Technologies stands as an attractive prospect for potential venture capital investment.
